James Bearden to Peripheral Nervous System Diseases
This is a "connection" page, showing publications James Bearden has written about Peripheral Nervous System Diseases.
Connection Strength
0.168
-
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011 Jun; 19(6):833-41.
Score: 0.093
-
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol. 2007 Jun 01; 25(16):2205-11.
Score: 0.075